| Literature DB >> 32056451 |
Mouna Sawan1,2, Emily Reeve3,4, Justin Turner5, Adam Todd6, Michael A Steinman7, Mirko Petrovic8, Danijela Gnjidic1,9.
Abstract
Introduction: There is increasing recognition of the need for deprescribing of inappropriate medications in older adults. However, efforts to encourage implementation of deprescribing in clinical practice have resulted in mixed results across settings and countries.Area covered: Searches were conducted in PubMed, Embase, and Google Scholar in June 2019. Reference lists, citation checking, and personal reference libraries were also utilized. Studies capturing the main challenges of, and opportunities for, implementing deprescribing into clinical practice across selected health-care settings internationally, and international deprescribing-orientated policies were included and summarized in this narrative review.Expert opinion: Deprescribing intervention studies are inherently heterogeneous because of the complexity of interventions employed and often do not reflect the real-world. Further research investigating enhanced implementation of deprescribing into clinical practice and across health-care settings is required. Process evaluations in deprescribing intervention studies are needed to determine the contextual factors that are important to the translation of the interventions in the real-world. Deprescribing interventions may need to be individually tailored to target the unique barriers and opportunities to deprescribing in different clinical settings. Introduction of national policies to encourage deprescribing may be beneficial, but need to be evaluated to determine if there are any unintended consequences.Entities:
Keywords: Deprescribing; deprescribing in practice; medication withdrawal; older adults; policies; polypharmacy
Mesh:
Year: 2020 PMID: 32056451 PMCID: PMC7309419 DOI: 10.1080/17512433.2020.1730812
Source DB: PubMed Journal: Expert Rev Clin Pharmacol ISSN: 1751-2433 Impact factor: 5.045